HOME >> MEDICINE >> NEWS
Myosin molecule walks like a person, experiment shows

n and his Illinois colleagues -- physics professor Taekjip Ha and graduate students Ahmet Yildiz and Sean McKinney -- developed a single-molecule imaging technique that is capable of locating the position of a fluorescent dye to within 1.5 nanometers. (One nanometer is a billionth of a meter, or about 10,000 times smaller than the width of a human hair). This localization represents a 20-fold improvement over other techniques that use fluorescent dyes.

The researchers also found a way to extend the lifetime of the dye from a few seconds to several minutes. Then they teamed up with physiology professor Yale Goldman and postdoctoral researcher Joseph Forkey, both at the University of Pennsylvania, in applying the technique to measuring myosin movement.

"First, we attach a little fluorescent dye to one of the feet and we take a picture with a digital camera attached to a microscope to find exactly where the dye is," Selvin said. "Then we feed the myosin a little food called adenosine triphosphate, and it takes a step. We take another picture, locate the dye, and accurately measure how far the dye moved."

By looking at the step size, the scientists can tell whether the protein is walking or inchworming along, Selvin said. If it is walking, the rear foot takes twice as big a step than if it were inchworming.

"The long dye lifetime allowed us to measure many consecutive steps, which occurred about once every 3 seconds," Selvin said. "The foot wearing the dye would move forward 74 nanometers, then pause while the unlabeled foot moved forward. The cycle would then repeat itself. The 74-nanometer step size we measured is consistent with a hand-over-hand walking mechanism and inconsistent with an inchworm mechanism."

As an additional check, the researchers also labeled the myosin higher up on the leg, "somewhere in the neighborhood of the thighbone," Selvin said. "The steps alternated in size between long and short, just as yo
'"/>

Contact: James E. Kloeppel, Physical Sciences Editor
kloeppel@uiuc.edu
217-244-1073
University of Illinois at Urbana-Champaign
5-Jun-2003


Page: 1 2 3

Related medicine news :

1. Myosin mutant points to human origins
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Chemists synthesize molecule that helps body battle cancers, malaria
4. Blocking molecules protects health of implants
5. ASU researchers demonstrate new nanotech effect - moving water molecules by light
6. Zengen reports positive phase I/II trial results of its peptide molecule for vaginal yeast infection
7. New molecule may be basis for drugs that battle overeating and drug dependency
8. Latest cancer research features small molecule therapy, and the preventative benefits of sunshine
9. Student builds micro biosensor chip to move DNA molecules
10. Laser method identifies, counts toxic molecules
11. Vision-producing cells fail taste-test, treat key light-detecting molecules identically

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Myosin molecule walks like person experiment shows

(Date:3/5/2015)... Southlake, TX (PRWEB) March 05, 2015 ... an in-office, non-surgical treatment for OB-GYNs and Urogynecologists. ... system, used for non-surgical dermatological application in aesthetics ... pleased to have a non-invasive, in-office procedure, and ... for women who want results without surgery. ThermiVa ...
(Date:3/5/2015)... Building on its commitment to provide ... The Academy of Oncology Nurse & Patient Navigators (AONN+) ... voice ™ (CONQUER ™). , “Cancer has ... and their loved ones each year,” says Pam Rattananont ... ever, there is a need in the oncology space ...
(Date:3/4/2015)... MyCpapStore.com, an online provider of CPAP equipment ... quality products designed to remedy the problem of snoring. ... merchandise from name-brand manufacturers, giving its customers access to ... Sleep apnea is a common condition affecting people of ... restricted airflow. The CPAP (continuous positive airway pressure) machine ...
(Date:3/4/2015)... Vegas, NV (PRWEB) March 04, 2015 In ... as the fight that is the main event. For ... and that fight will be for the UFC Featherweight Championship. ... the brash, often out-spoken native of Ireland, Conor “Notorious” McGregor. ... MGM Grand Garden Arena in Las Vegas, NV. , When ...
(Date:3/4/2015)... Dr. Christopher Asandra, M.D., Founder and Chief ... lamented the FDA’s recent decision to issue a ... that FDA’s conclusions are not supported by science, and ... testosterone deficiency. , “The FDA appears to have developed ... said Dr. Asandra. “There is not nearly enough evidence ...
Breaking Medicine News(10 mins):Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 2Health News:ThermiHealth Announces the Introduction of ThermiVa in North America to OB-GYNs 3Health News:The Academy of Oncology Nurse & Patient Navigators Launches CONQUER: the patient voice™ to Help Meet the Informational Needs of Patients with Cancer 2Health News:Sleep Apnea Machines CPAP and BiPap Machines Now Available for Sale 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2
(Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... in Miami, FL on Wednesday, March ... webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... Texas , March 4, 2015 ... II pilot study in patients with moderate to ... Dermatology. The open-label Phase II trial evaluated the ... monoclonal antibody that targets interleukin-1 alpha (IL-1a). IL-1a ... inflammatory cells present in skin lesions. The Company ...
(Date:3/4/2015)... Pa. , March 4, 2015  Results of ... 100 Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin ... poster session at the 32 nd Annual Miami ... study, conducted by Moshe Papa , MD, FACS, ... at Tel Aviv University, reports an analysis of MarginProbe,s ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2
Cached News: